Proteomic technologies and their application to pancreatic cancer

Expert Review of Proteomics

Volumn 1, Issue 4, 2004, Pages 493-501

  Vimalachandran, Dale ^a   Costello, Eithne ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

2DE; LCM; Mass spectrometry; Pancreatic cancer; SELDI

Indexed keywords

BIOLOGICAL MARKER; TUMOR PROTEIN;

BIOINFORMATICS; BIOTECHNOLOGY; CANCER CELL; CANCER DIAGNOSIS; CANCER RESEARCH; CANCER STAGING; CANCER TISSUE; HUMAN; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PROTEIN ANALYSIS; PROTEOMICS; REVIEW; CHEMISTRY; DNA MICROARRAY; GENETICS; MASS SPECTROMETRY; METHODOLOGY; PANCREAS TUMOR; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33645222221     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.1.4.493     Document Type: Review

References (54)

1. National Cancer Institute. Estimated new cancer cases and deaths for 2004. SEER Cancer Statistics Review 1975-2001. (2004).
2. Bonelli L, Aste H, Bovo P et al. Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case control study in Northern Italy. Pancreas 27, 143-149 (2003).
3. Ghadirian P, Lynch HT, Krewski D. Epidemiology of pancreatic cancer. Cancer Detect. Prev. 27, 87-93 (2003).
4. Howes N, Neoptolemos JP. Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis. Gut 51, 765-766 (2002).
5. Vimalachandran CD, Ghaneh P, Costello E, Neoptolemos JP. Genetics and the prevention of pancreatic cancer. Cancer Control 11, 1-9 (2004).
6. Kim JE, Lee KT, Lee JK et al. Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J. Gastroenterol. Hepatol. 19, 182-186 (2004).
7. Kern SE, Hrubran R, Hollingsworth MA et al. A white paper: the product of a pancreas cancer think tank. Cancer Res. 61, 4923-4932 (2001).
8. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nature Rev. 2, 897-909 (2002). Excellent review on the molecular pathology of pancreatic cancer.
9. Jemal A, Thomas A, Murray A, Thun M. Cancer statistics 2002. CA Cancer J. Clin. 52, 23-47 (2002).
10. Sener S, Frengen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J. Am. Coll. Surg. 189, 1-7 (1999).
11. Neoptolemos JP, Stocken DD, Friess H et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N. Engl. J. Med. 350, 1200-1210 (2004). Demonstrates the benefit of chemotherapy in the adjuvant setting for pancreatic cancer patients.
12. Liotta L, Petricoin P. Molecular profiling of human cancer. Nature Rev. 1, 48-56 (2000).
13. Sgroi DC, Teng S, Robinson G et al. In vivo gene expression profiling analysis. Cancer Res. 59, 5656-5661 (1999).
14. Goldsworthy SM, Stockton PS, Trempus CS et al. Effects of fixation on RNA extraction and amplification from laser microdissected tissue. Mol. Carcinog. 25, 86-91 (1999).
15. Caldas C, Hahn SA, da Costa LT et al. Frequent somatic mutations and homozygous deletions of the p16(MTS1) gene in pancreatic adenocarcinoma. Nature Genet. 8, 27-32 (1994).
16. Schutze K, Lahr G. Identification of expressed genes by laser-mediated manipulation of single cells. Nature Biotechnol. 16, 737-742 (1998).
17. Shekouh A, Thompson CC, Prime W et al. Development and application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics 3, 1988-2001 (2003). 2D electrophoresis (2DE)/matrix-assisted laser desorption/ionization applied to detect differential protein expression between microdissected normal and malignant pancreatic tissue.
18. Scheele GA. Two dimensional electrophoresis in basic and clinical research, exemplified by studies on the exocrine pancreas. Clin. Chem. 28, 1056-1061 (1982).
19. Shi X, Liu S, Kleef J, Friess H, Buchler M. Acquired resistance of pancreatic cancer cells towards 5-flurouracil and gemcitabine is associated with altered expression of apoptosis related genes. Oncology 62, 354-362 (2002).
20. Moller A, Malerczyk C, Volker U, Stoppler H, Masser E. Monitoring danorubicin induced alterations in protein expression in pancreas carcinoma cells by two dimensional electrophoresis. Proteomics 2, 697-705 (2002).
21. Moller A, Soldan M, Volker U, Maser E. Two dimensional electrophoresis: a powerful method to elucidate cellular responses to toxic compounds. Toxicology 160, 129-138 (2001).
22. Cecconi D, Astner H, Donadelli M et al. Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2′-deoxycytidine. Electrophoresis 24, 4291-4303 (2003).
23. Cecconi D, Scarpa A, Donadelli M et al. Proteomic profiling of pancreatic ductal carcinoma cell line treated with trichostatin A. Electrophoresis 24, 1871-1878 (2003).
24. Sinha P, Hutter G, Kottgen E et al. Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-σ (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electrophoresis 20, 2952-2960 (1999).
25. Poland J, Urbani A, Lage H, Schnolzer M, Sinha P. Study of the development of thermoresistance in human pancreatic carcinoma cell lines using proteome analysis. Electrophoresis 25, 175-183 (2004).
26. Hu L, Evers S, Lu ZH, Shen Y, Chen J. Two dimensional protein database of human pancreas. Electrophoresis 25, 512-518 (2004).
27. Patton WF, Schulenberg B, Steinberg T. Two dimensional electrophoresis; better than a poke in the ICAT. Curr. Opin. Biotechnol. 13, 321-328 (2002).
28. Link A, Eng J, Schieltz DM et al. Direct analysis of protein complexes using mass spectrometry. Nature Biotechnol. 17, 676-682 (1999).
29. Gorg A, Obermaier C, Boguth G et al. The current state of two-dimensional electrophoresis with immobilised pH gradients. Electrophoresis 21, 1037-1053 (2000).
30. Hanash SM. Biomedical applications of two-dimensional electrophoresis using immobilised pH gradients: current status. Electrophoresis 21, 1202-1209 (2000).
31. Patton WF. A thousand points of light: the application of fluorescence detection technologies to two-dimensional gel electrophoresis and proteomics. Electrophoresis 21, 1123-1144 (2000).
32. Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18, 2071-2077 (1997).
33. Westermeier R, Naven T. In: Proteomics in Practice. Wiley VCH, Weinheim, Germany (2002). Excellent reference material of practical proteomics, in particular 2DE.
34. Smith RD. Trends in mass spectrometry instrumentation for proteomics. Trends Biotechnol. 12(Suppl.), S3-S7 (2002).
35. Liotta L, Ferrari M, Petricoin P. Written in blood. Nature 425, 905 (2003).
36. Valerio A, Basso D, Mazza S et al. Serum protein profiles of patients with pancreatic cancer and chronic pancreatitis: searching for a diagnostic protein pattern. Rapid Comm. Mass Spec. 15, 2420-2425 (2001).
37. Templin MF, Stoll D, Schwenk JM et al. Protein microarrays: promising tools for proteomic research. Proteomics 3, 2155-2166 (2003). Detailed review of protein microarray technology.
38. Melton L. Protein arrays: proteomics in multiplex. Nature 429, 101-107 (2004).
39. Issaq HJ, Veenstra TD, Conrads TP, Felschow D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Comm. 292, 587-592 (2002).
40. Koopman J, Zhang Z, White N et al. Serum diagnosis of pancreatic adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry. Clin. Canc. Res. 10, 860-868 (2004).
41. Wandschneider S, Fehring V, Jacobs-Emesis S, Thiesen HJ, Lohr M. Autoimmune pancreatic disease: preparation of pancreatic juice for proteome analysis. Electrophoresis 22, 4383-4390 (2001).
42. Rosty C, Christa L, Kudzal S et al. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis associated protein 1 as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res. 62, 1868-1875 (2002).
43. Hruban RH, van Mansfield ADM, Offerhaus GJA et al. K-ras oncogene activation in adenocarcinomas of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am. J. Pathol. 143, 545-554 (1993).
44. Hingorani SR, Petricoin EF, Maitra A et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 4, 437-450 (2003).
45. Tang N, Tornatore P, Weinberger SR. Current developments in SELDI affinity technology. Mass Spec. Rev. 23, 34-44 (2004). Very good review on surface-enhanced laser desorption/ionization technology and its application as a diagnostic platform.
46. James P. Chips for proteomics: a new tool or just hype. Biotechniques 33, S4-S13 (2002).
47. Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI TOF protein patterns in serum: comparing data sets from different experiments. Bioinformatics 22, 777-785 (2004).
48. Fenyo D, Beavis RC. Informatics and data management in proteomics. Trends Biotechnol. 20(S), S35-S38 (2002). Good summary of the data management issues in proteomics.
49. Bader GD, Hogue CW. BIND-data specification for storing and describing biomolecular interactions, molecular complexes and pathways. Bioinformatics 16, 465-477 (2000).
50. Ho Y, Gruhler A, Heilbut A et al. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415, 180-183 (2002).
51. White CN, Chan D, Zhang Z. Bioinformatics strategies for proteomic profiling. Clin. Biochem. 37, 636-641 (2004).
52. Diamandis EP. Point: patterns in biological fluids: do they represent the future of cancer diagnostics? Clin. Chem. 49, 1272-1275 (2003).
53. Apweiler R, Bairoch A, Wu CH et al. UniProt: the universal protein knowledge database. Nucleic Acids Res. 32, D115-D119 (2004).
54. Farriol-Mathis N, Garavelli JS, Boeckmann B et al. Annotation of post-translational modifications in the Swiss-Prot knowledge base. Proteomics 4, 1537-1550 (2004).